ArticleAntimicrobial agents and chemotherapy2008
Novel insertion sequence- and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky.
Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 78 citations in OpenAlex.
- Global phylogeography and genomic characterization ofmSystems · 2025Article
- Highly drug resistant clone of Salmonella Kentucky ST198 in clinical infections and poultry in Zimbabwe.npj antimicrobials and resistance · 2023Article
- Genomic characterization of multidrug-resistantMicrobial genomics · 2022Article
- Genomic and Evolutionary Analysis ofFrontiers in cellular and infection microbiology · 2022Article
- Multilocus sequence typing of multidrug-resistant Salmonella strains circulating in poultry farms of Bangladesh.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021Article
- IncC helper dependent plasmid-like replication of Salmonella Genomic Island 1.Nucleic acids research · 2021Article
- Genomic Analysis of Ciprofloxacin-ResistantFrontiers in microbiology · 2021Article
- Two New SGI1-LK Variants Found in Proteus mirabilis and Evolution of the SGI1-HKL Group ofmSphere · 2020Article
- Ciprofloxacin-ResistantMicroorganisms · 2020Article
- Extended-Spectrum β-Lactamases in Human Isolates of Multidrug-Resistant Non-typhoidalFrontiers in microbiology · 2020Article
- Genomic Sequence Analysis of the Multidrug-Resistance Region of AvianMicroorganisms · 2019Article
- Global phylogenomics of multidrug-resistant Salmonella enterica serotype Kentucky ST198.Microbial genomics · 2019Article
- ISFrontiers in microbiology · 2019Article
- Systemic Administration of Avian Defensin 7: Distribution, Cellular Target, and Antibacterial Potential in Mice.Frontiers in microbiology · 2019Article
- Identification and Characterization ofFrontiers in microbiology · 2019Article
- Identification and Characterization of New Resistance-Conferring SGI1s (Frontiers in microbiology · 2018Article
- "Does the Salmonella Genomic Island 1 (SGI1) confer invasiveness properties to human isolates?"BMC infectious diseases · 2017Article
- Characterization of Novel Integrons, InFrontiers in microbiology · 2017Article
- Detection of SGI1/PGI1 Elements and Resistance to Extended-Spectrum Cephalosporins inFrontiers in microbiology · 2017Article
- The risk of carriage ofVeterinary medicine and science · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salmonella genomic island 1 (SGI1) is an integrative mobilizable element that harbors a multidrug resistance (MDR) gene cluster. Since its identification in epidemic Salmonella enterica serovar Typhimurium DT104 strains, variant SGI1 MDR gene clusters conferring different MDR phenotypes have been identified in several S. enterica serovars and classified as SGI1-A to -O. A study was undertaken to characterize SGI1 from serovar Kentucky strains isolated from travelers returning from Africa. Several strains tested were found to contain the partially characterized variant SGI1-K, recently described in a serovar Kentucky strain isolated in Australia. This variant contained only one cassette array, aac(3)-Id-aadA7, and an adjacent mercury resistance module. Here, the uncharacterized part of SGI1-K was sequenced. Downstream of the mer module similar to that found in Tn21, a mosaic genetic structure was found, comprising (i) part of Tn1721 containing the tetracycline resistance genes tetR and tet(A); (ii) part of Tn5393 containing the streptomycin resistance genes strAB, IS1133, and a truncated tnpR gene; and (iii) a Tn3-like region containing the tnpR gene and the beta-lactamase bla(TEM-1) gene flanked by two IS26 elements in opposite orientations. The rightmost IS26 element was shown to be inserted into the S044 open reading frame of the SGI1 backbone. This variant MDR region was named SGI1-K1 according to the previously described variant SGI1-K. Other SGI1-K MDR regions due to different IS26 locations, inversion, and partial deletions were characterized and named SGI1-K2 to -K5. Two new SGI1 variants named SGI1-P1 and -P2 contained only the Tn3-like region comprising the beta-lactamase bla(TEM-1) gene flanked by the two IS26 elements inserted into the SGI1 backbone. Three other new variants harbored only one IS26 element inserted in place of the MDR region of SGI1 and were named SGI1-Q1 to -Q3. Thus, in serovar Kentucky, the SGI1 MDR region undergoes recombinational and insertional events of transposon and insertion sequences, resulting in a higher diversity of MDR gene clusters than previously reported and consequently a higher diversity of MDR phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.